| Literature DB >> 32210042 |
Giang Thu Vu1, Bach Xuan Tran2,3, Chi Linh Hoang4, Brian J Hall3,5, Hai Thanh Phan6, Giang Hai Ha6, Carl A Latkin3, Cyrus S H Ho7, Roger C M Ho4,8,9.
Abstract
Quality of life (QOL) has been considered as an important outcome indicator in holistic care for HIV-infected people, especially as HIV/AIDS transforms from a fatal illness to a chronic condition. This study aimed to identify trends and emerging topics among research concerning the QOL of people living with HIV/AIDS (PLWHA). The analyzed data were English papers published from 1996 to 2017, searched and extracted from the Web of Science Core Collection. Collaborations between countries and the correlation between the keywords were visualized by VOSviewer while the abstracts' content was analyzed using exploratory factor analysis and Jaccard's' similarity index. There has been an increase in both the number of publications and citations. The United Nations of America leads in terms of paper volume. The cross-nation collaborations are mainly regional. Despite a rather comprehensive coverage of topics relating to QOL in PLWHA, there has evidently been a lack of studies focusing on socio-cultural factors and their impacts on the QOL of those who are HIV-infected. Further studies should consider investigating the role of socio-cultural factors, especially where long-term treatment is involved. Policy-level decisions are recommended to be made based on the consideration of cultural factors, while collaborations between developed and developing nations, in particular in HIV/AIDS-ridden countries, are strongly recommended.Entities:
Keywords: HIV/AIDS; bibliometric; quality of life; scientometrics
Year: 2020 PMID: 32210042 PMCID: PMC7143369 DOI: 10.3390/ijerph17062127
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure A1Selection of papers. The searching and paper selection process identified 250,270 related to HIV/AIDS. Among those, 2818 papers included the terms “quality of life”.
Summary of the techniques and methods.
| Type of Data | Unit of Analysis | Analytical Methods | Presentations of Results |
|---|---|---|---|
| Abstracts | Words | Frequency of co-occurrence | 1. The number of articles by countries mentioned in the abstract |
| Abstracts | WoS research domains | Exploratory factor analysis | 1. Top 50 research domains |
| Abstracts | Words | Jaccard’s similarity index | 1. Top 50 most frequent co-occurrence terms |
General indicators of publications
| Year Published | Total Number of Papers | Total Citations | Mean Cite Rate per Year 1 | Total Usage* Last 6 Months | Total Usage* Last 5 Years | Mean Use Rate Last 6 Months 2 | Mean Use Rate Last 5 Years 3 |
|---|---|---|---|---|---|---|---|
| 2017 | 234 | 11,965 | 51.1 | 356 | 1,151 | 1.5 | 1.0 |
| 2016 | 215 | 11,221 | 26.1 | 211 | 1,619 | 1.0 | 1.5 |
| 2015 | 218 | 10,985 | 16.8 | 174 | 1,972 | 0.8 | 1.8 |
| 2014 | 211 | 9,638 | 11.4 | 107 | 1,891 | 0.5 | 1.8 |
| 2013 | 213 | 9,866 | 9.3 | 96 | 2,286 | 0.5 | 2.1 |
| 2012 | 185 | 8,773 | 7.9 | 52 | 1,692 | 0.3 | 1.8 |
| 2011 | 169 | 8,476 | 7.2 | 65 | 1,315 | 0.4 | 1.6 |
| 2010 | 167 | 7,462 | 5.6 | 46 | 1,160 | 0.3 | 1.4 |
| 2009 | 140 | 6,445 | 5.1 | 62 | 908 | 0.4 | 1.3 |
| 2008 | 122 | 5,468 | 4.5 | 53 | 818 | 0.4 | 1.3 |
| 2007 | 114 | 5,639 | 4.5 | 33 | 622 | 0.3 | 1.1 |
| 2006 | 96 | 4,588 | 4.0 | 41 | 606 | 0.4 | 1.3 |
| 2005 | 112 | 5,265 | 3.6 | 61 | 767 | 0.5 | 1.4 |
| 2004 | 80 | 3,746 | 3.3 | 36 | 414 | 0.4 | 1.0 |
| 2003 | 73 | 3,012 | 2.8 | 25 | 374 | 0.3 | 1.0 |
| 2002 | 58 | 2,579 | 2.8 | 10 | 226 | 0.2 | 0.8 |
| 2001 | 51 | 2,163 | 2.5 | 11 | 264 | 0.2 | 1.0 |
| 2000 | 66 | 2,759 | 2.3 | 11 | 309 | 0.2 | 0.9 |
| 1999 | 49 | 2,291 | 2.5 | 13 | 212 | 0.3 | 0.9 |
| 1998 | 56 | 2,385 | 2.1 | 16 | 214 | 0.3 | 0.8 |
| 1997 | 39 | 1,708 | 2.1 | 7 | 128 | 0.2 | 0.7 |
| 1996 | 44 | 1,455 | 1.5 | 11 | 169 | 0.3 | 0.8 |
* Usage: downloaded time; 1 Mean cited rate per year = Total citations/(Total citations × (2018-that year)); 2 Mean usage rate last 6 months = Total usage last 6 months/Total number of papers; 3 Mean use rate last 5 years = total usage last 5 years/(total number of papers × 5).
A number of papers by countries as study settings.
| No. | Country Settings | Frequency | % | No. | Country Settings | Frequency | % |
|---|---|---|---|---|---|---|---|
| 1 | United States | 271 | 21.1% | 31 | Sweden | 8 | 0.6% |
| 2 | South Africa | 108 | 8.4% | 32 | Zambia | 8 | 0.6% |
| 3 | India | 74 | 5.8% | 33 | Cambodia | 7 | 0.5% |
| 4 | Brazil | 60 | 4.7% | 34 | Ghana | 7 | 0.5% |
| 5 | China | 60 | 4.7% | 35 | Lesotho | 7 | 0.5% |
| 6 | Uganda | 52 | 4.0% | 36 | Netherlands | 7 | 0.5% |
| 7 | Canada | 42 | 3.3% | 37 | Swaziland | 7 | 0.5% |
| 8 | Thailand | 32 | 2.5% | 38 | Switzerland | 7 | 0.5% |
| 9 | United Kingdom | 30 | 2.3% | 39 | Hong Kong | 6 | 0.5% |
| 10 | Australia | 29 | 2.3% | 40 | Jamaica | 6 | 0.5% |
| 11 | Ethiopia | 27 | 2.1% | 41 | Japan | 6 | 0.5% |
| 12 | Niger | 25 | 1.9% | 42 | Nepal | 6 | 0.5% |
| 13 | Nigeria | 25 | 1.9% | 43 | Germany | 5 | 0.4% |
| 14 | Malawi | 21 | 1.6% | 44 | Mexico | 5 | 0.4% |
| 15 | Viet Nam | 20 | 1.6% | 45 | Peru | 5 | 0.4% |
| 16 | Ireland | 19 | 1.5% | 46 | Wallis and Futuna | 5 | 0.4% |
| 17 | Taiwan | 18 | 1.4% | 47 | Colombia | 4 | 0.3% |
| 18 | Rwanda | 17 | 1.3% | 48 | Georgia | 4 | 0.3% |
| 19 | Kenya | 15 | 1.2% | 49 | Haiti | 4 | 0.3% |
| 20 | Iran | 14 | 1.1% | 50 | Jersey | 4 | 0.3% |
| 21 | Spain | 14 | 1.1% | 51 | Portugal | 4 | 0.3% |
| 22 | Tanzania | 14 | 1.1% | 52 | Romania | 4 | 0.3% |
| 23 | Zimbabwe | 14 | 1.1% | 53 | Singapore | 4 | 0.3% |
| 24 | Malaysia | 13 | 1.0% | 54 | Burkina Faso | 3 | 0.2% |
| 25 | Cameroon | 12 | 0.9% | 55 | Democratic Republic of the Congo | 3 | 0.2% |
| 26 | Italy | 12 | 0.9% | 56 | Republic of the Congo | 3 | 0.2% |
| 27 | France | 11 | 0.9% | 57 | Finland | 3 | 0.2% |
| 28 | Botswana | 9 | 0.7% | 58 | Guinea | 3 | 0.2% |
| 29 | Indonesia | 9 | 0.7% | 59 | Lebanon | 3 | 0.2% |
| 30 | Puerto Rico | 8 | 0.6% | 60 | Mali | 3 | 0.2% |
Figure 1The network of 102 countries having international co-authorships in quality of life research in HIV/AIDS.
Figure 2The most common author keywords. Note: the principal components of the data structure were visualized regarding the colors of the nodes; the node size was identified by the keywords’ occurrences; the closer the nodes are, the stronger the association between two keywords are.
Top 50 research domains emerged from exploratory factor analysis of all abstracts’ contents.
| Name | Keywords | Eigen Value | FREQ | % Cases |
|---|---|---|---|---|
| Mental health summary | Medical Outcomes Study (MOS); summary; mental; survey; physical; scores; medical; score; health related quality of life (HRQOL); outcomes; short form (SF) | 26.1 | 4123 | 62.60% |
| Criteria; controlled trials | Criteria; trials; objectives; controlled; main; evidence; performed; review; evaluate | 1.9 | 2357 | 48.90% |
| The World Health Organization Quality of Life brief | WHOQOL; BREF; Domain; domains; world; version; QOL; psychological; social | 3.3 | 2335 | 44.20% |
| Randomized; Controlled trial | Randomized; trial; placebo; controlled; weeks; week; groups; primary; intervention | 7.2 | 2312 | 39.30% |
| Cost-effectiveness; costs | Cost; costs; effectiveness; effective; economic; model; year | 1.9 | 1643 | 37.50% |
| Coping strategies; social support | Coping; strategies; support; social | 1.3 | 1522 | 37.10% |
| Depressive; anxiety and depression | Depressive; depression; symptoms; anxiety; psychiatric; psychological | 2.7 | 1722 | 36.10% |
| Reliability and validity; item scale | Validity; reliability; item; items; instrument; factor; scales; measure; good; scale | 2.2 | 1923 | 36.10% |
| Care access | Access; services; care | 1.3 | 1220 | 33.40% |
| Role functioning | Role; function; cognitive; functioning | 1.5 | 1025 | 27.30% |
| Viral load; count | Load; viral; count; counts; cells | 1.8 | 1384 | 27.00% |
| Literature; review | Literature; review; evidence | 5 | 919 | 24.10% |
| Sex; men and women | Sexual; men; sex; women | 1.8 | 1002 | 23.90% |
| Chronic conditions | Conditions; chronic; diseases | 1.6 | 840 | 23.40% |
| Stigma; disclosure | Stigma; disclosure; perceived; negative | 3.7 | 837 | 23.20% |
| Cross-sectional | Sectional; cross; prevalence | 2.5 | 1128 | 23.00% |
| Side effects | Side; effects | 1.5 | 815 | 22.80% |
| Follow-up period | Period; follow; month; year | 2.3 | 852 | 22.50% |
| Body mass; fat loss | Mass; body; fat; weight; kg; loss; nutritional; exercise; testosterone; index | 3.3 | 1169 | 21.40% |
| Drug users | Users; methadone; drug; substance | 2.3 | 766 | 21.00% |
| Outcome measures | Outcome; measures | 1.3 | 718 | 20.60% |
| Control | Controls; control; intervention | 1.7 | 712 | 20.10% |
| Anti; development | Anti; development; resistance; therapeutic | 1.2 | 712 | 19.70% |
| Palliative; cancer pain | Palliative; cancer; advanced; pain | 1.9 | 620 | 18.20% |
| Adherence to medication | Medication; adherence | 1.6 | 639 | 18.10% |
| Developed countries | Countries; developed; settings | 1.2 | 600 | 18.00% |
| Screening; early | Screening; early; settings | 1.2 | 500 | 15.50% |
| Combination | Combination; response | 1.3 | 416 | 13.50% |
| Demographic | Demographic; characteristics | 1.5 | 456 | 13.40% |
| Children | Children; adoslescents; caregivers; family | 1.7 | 499 | 13.30% |
| EuroQOL (EQ); HRQOL demension | EQ; HRQOL; Dimensions | 1.6 | 445 | 13.30% |
| Reduction | Reduction; improvement | 1.4 | 407 | 13.10% |
| Morbidity and mortality | Mortality; morbidity | 1.7 | 497 | 12.60% |
| Inhibitor; protease inhibitor (PI) regimens | Inhibitor; PI; regimen; regimens | 3.1 | 498 | 12.20% |
| Death | Death; hospital | 1.3 | 357 | 12.00% |
| Emotional | Emotional; functional | 1.3 | 358 | 11.80% |
| Exercise | Exercise; activity; week | 1.3 | 374 | 11.70% |
| Moderate to severe | Severe; moderate; haemophilia | 1.5 | 390 | 11.70% |
| Long-term | Term; long | 2.1 | 522 | 11.20% |
| Adverse effect | Events; adverse | 1.4 | 426 | 11.20% |
| Cytomegalovirus (CMV); Prophylaxis | CMV; prophylaxis; infections | 1.4 | 348 | 10.80% |
| South Africa | South; Africa | 2 | 344 | 8.60% |
| Food | Food; people living with HIV (PLHIV); nutritional | 1.3 | 225 | 6.90% |
| Facial | Facial; satisfaction | 1.3 | 177 | 5.90% |
| Hepatitis | Hepatitis; hepatitis C virus (HCV) | 1.9 | 215 | 5.60% |
| Sleep | Sleep; fatigue | 1.4 | 155 | 4.80% |
| Failure | Failure | 1.4 | 120 | 4.30% |
| Anemia | Anemia | 1.4 | 49 | 1.70% |
| Diarrhea | Diarrhea | 1.5 | 44 | 1.60% |
| Tuberculosis (TB) | TB | 1.4 | 38 | 1.40% |
Figure 3Proximity Plots of “quality of life” with the top 50 most frequent concurrence terms in abstracts.